Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 612
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT05177523 INsIDER — Imaging the Interplay Between Axonal Damage and Repair in Mul… |
INsIDER — Imaging the Interplay B… | SEP | À vérifier | RECRUITING | En attente / non publié | University Hospital, Basel, Switz… | Switzerland · University Hospital Basel, Department o… | 2018-09-04 → 2028-12 | Ouvrir |
| NCT01465087 Nanotechnology for Detection of Multiple Sclerosis Compared to Autoimmu… |
Nanotechnology for Detection of M… | SEP | Non applicable | COMPLETED | En attente / non publié | Carmel Medical Center | Israel · Multiple Sclerosis Clinic, Carmel Medical Ce… | 2011-12 → 2015-01 | Ouvrir |
| NCT05359653 ReVIVE — Assessing Changes in Multi-parametric MRI in MS Patients Takin… |
Clemastine Fumarate | SEP | Phase 1 | RECRUITING | En attente / non publié | University of California, San Fra… | United States · Sandler Neurosciences Building, Neuro… | 2023-08-01 → 2027-06-01 | Ouvrir |
| NCT07202494 MESO7 — Integrating Metabolism, Connectivity, and Mesoscale Imaging at … |
MESO7 — Integrating Metabolism, C… | SEP | À vérifier | RECRUITING | En attente / non publié | Assistance Publique Hopitaux De M… | France · Chu Timone, Marseille, France | 2025-05-19 → 2030-05-18 | Ouvrir |
| NCT05298670 Drug Repurposing Using Metformin for Improving the Therapeutic Outcome … |
MetFORMIN 1000 Mg Oral Tablet | SEP | Phase 2 | UNKNOWN | En attente / non publié | German University in Cairo | Egypt · Nasser Institute for Research and Treatment, … | 2022-02-01 → 2023-03-28 | Ouvrir |
| NCT00127075 POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estra… |
nomegestrol acetate | SEP | Phase 3 | UNKNOWN | En attente / non publié | Hospices Civils de Lyon | France · Hôpital Pierre Wertheimer, Bron, France | 2005-06 → 2012-04 | Ouvrir |
| NCT01395316 Alemtuzumab on Surrogate Markers of Disease Activity and Repair Using A… |
Alemtuzumab | SEP | Phase 4 | COMPLETED | En attente / non publié | Northside Hospital, Inc. | Non communiqué | 2011-06 → 2017-07 | Ouvrir |
| NCT05131828 CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Tri… |
Metformin and clemastine in combi… | SEP | Phase 2 | COMPLETED | En attente / non publié | Cambridge University Hospitals NH… | United Kingdom · Addenbrooke's Hospital, Cambridge, U… | 2022-03-08 → 2025-09-26 | Ouvrir |
| NCT00937677 Effect of Tysabri in Patients With Relapsing-Remitting Multiple Scleros… |
Tysabri | SEP | À vérifier | COMPLETED | En attente / non publié | Kessler Foundation | United States · Jacobs Neurological Institute, Buffal… | 2007-11 → 2010-11 | Ouvrir |
| NCT02521545 Single-Dose Study of a New Formulation of BIIB061 |
BIIB061 | SEP | Phase 1 | COMPLETED | En attente / non publié | Biogen | United States · Research Site, Madison, United States | 2015-07 → 2015-08 | Ouvrir |
| NCT07710105 Ocrevus Zunovo for MS: Mixed Methods |
Ocrevus Zunovo | SEP | À vérifier | RECRUITING | En attente / non publié | Northwestern University | United States · Northwestern Memorial Hospital, Chica… | 2026-06-12 → 2028-12 | Ouvrir |
| NCT04035005 O'HAND — A Study to Evaluate the Efficacy and Safety of Ocrelizumab in … |
Ocrelizumab | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Australia, Belgium, Bulgaria, Canada, … | 2019-08-12 → 2028-01-19 | Ouvrir |
| NCT01765361 Assessment of Ocrelizumab (OCR) Treatment Effects on Functional Impairm… |
Assessment of Ocrelizumab (OCR) T… | SEP | À vérifier | COMPLETED | En attente / non publié | University Hospital, Basel, Switz… | Switzerland · Dep. Neurology, Hospital of the Univers… | 2012-09 → 2017-01 | Ouvrir |
| NCT05269004 OLERO — A Rollover Study to Evaluate the Long-Term Safety and Efficacy … |
Ocrelizumab | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Argentina, Australia, Austria, Belarus… | 2022-05-03 → 2027-12-31 | Ouvrir |
| NCT07321093 MUSCAT — A Study of the Efficacy and Safety of BCD-281 in Patients With… |
BCD-281 | SEP | Phase 3 | RECRUITING | En attente / non publié | Biocad | Russia · LLC "Medis", Nizhny Novgorod, Russia | 2025-11-01 → 2028-12 | Ouvrir |
| NCT07389590 Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis |
Ublituximab | SEP | Phase 4 | RECRUITING | En attente / non publié | TG Therapeutics, Inc. | United States · Johns Hopkins University, Baltimore, … | 2026-02-10 → 2029-03 | Ouvrir |
| NCT03600779 ihMTMS — Application of ihMT MRI in Multiple Sclerosis |
inhomogeneous Magnetisation Trans… | SEP | Non applicable | RECRUITING | En attente / non publié | Assistance Publique Hopitaux De M… | France · Assistance Publique Des Hotipaux de Marseill… | 2018-06-14 → 2028-08-14 | Ouvrir |
| NCT06233370 PRIMERS — Acute Effects of Walking Exercise on Brain Functioning in Mul… |
PRIMERS — Acute Effects of Walkin… | SEP | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Kessler Foundation | United States · Kessler Foundation, West Orange, Unit… | 2024-03-01 → 2026-12-31 | Ouvrir |
| NCT07749157 NOVA-BEAM — A Study of Subcutaneously Administered RO7845860 in Partici… |
RO7845860 | SEP | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Hoffmann-La Roche | Non communiqué | 2026-11-23 → 2031-02-28 | Ouvrir |
| NCT05797740 Cladribine Tablets Level of Response Predictors in Clinical Practice (C… |
Mavenclad | SEP | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | Merck Healthcare KGaA, Darmstadt,… | Belgium, Czechia, Greece, Netherlands, Poland, Portug… | 2023-08-03 → 2029-01-31 | Ouvrir |
| NCT05998616 FERLAMS — Feasibility of Remote Exercise Training for Hispanics/Latinos… |
FERLAMS — Feasibility of Remote E… | SEP | Non applicable | TERMINATED | En attente / non publié | University of Illinois at Chicago | United States · University of Illinois at Chicago, Ch… | 2024-04-27 → 2025-12-31 | Ouvrir |
| NCT07168772 PROBiMS — The Effect of a Probiotic Administration as an add-on Treatme… |
PROBiMS — The Effect of a Probiot… | SEP | Non applicable | RECRUITING | En attente / non publié | Hospital Universitari Vall d'Hebr… | Spain · Centre d'Esclerosi Mútiple de Catalunya (Cemc… | 2025-07-10 → 2027-12-31 | Ouvrir |
| NCT06869785 FILIOS — Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of… |
Ofatumumab approved dose | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Puerto Rico · Advent Neurology Clinic,… | 2025-03-13 → 2030-03-23 | Ouvrir |
| NCT06451159 A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Tre… |
KYV-101 (Biological) - 0.33 ×10^8… | SEP | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Bruce Cree | United States · University of California, San Francis… | 2024-06-20 → 2027-02 | Ouvrir |
| NCT01892722 Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple S… |
Interferon beta-1a | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | German University in Cairo | United States, Australia, Austria, Brazil, Bulgaria, … | 2013-07-26 → 2030-02-18 | Ouvrir |